Education > Virco HIV Tool Kits

The virco® TYPE HIV-1 Report provides clinicians with quantitative HIV resistance information to assist them in making informed treatment decision for patents living with HIV/AIDS.

The following toolkits have been developed by Virco to explain the rationale for developing the virco®TYPE HIV-1 Report and to assist HIV clinicians in better understanding the analytical processes used to transform an abundance of data into relevant clinical information


01-Introduction to Resistance Testing [July 2008]

Introduces three commercially available modalities of resistance testing and describes the data generated by each

Adobe Acrobat Format

Microsoft Powerpoint Format


02A-The Science Behind the virco®TYPE HIV-1 Report: Generating a virco®TYPE HIV-1 Report [July 2008]

Describes the methodologies employed by Virco to calculate fold-change values (a quantitative measure of HIV drug resistance) from its extensive correlative database of genotypes and phenotypes on clinical isolates.

Adobe Acrobat Format

Microsoft Powerpoint Format


02B-The Science Behind the virco®TYPE HIV-1 Report: Clinical Cut-Offs, Virco's Approach [July 2008]

Describes the data and methods used by Virco to establish the clinical cut-offs that are used to assess patient results on the vircoŽTYPE HIV-1 report.

Adobe Acrobat Format

Microsoft Powerpoint Format


03-How to read the virco®TYPE HIV-1 v4.2.01 HIV-1 Report [July 2008]

Provides a detailed explanation of how to read and use the virco®TYPE HIV-1 Report

Adobe Acrobat Format

Microsoft Powerpoint Format